Rep. Gilbert Ray Cisneros Jr. (D-CA) Sells Corteva (CTVA) Stock
Rep. Gilbert Ray Cisneros Jr. recently sold shares of Corteva, valued between $1,001 and $15,000, as reported under the STOCK Act.
Reviewed by automated data checks against the source filing. How we make and check alerts
Rep. Gilbert Ray Cisneros Jr. (D-CA) sold between $1,001 and $15,000 of Corteva, Inc. ($CTVA) stock on September 17, 2026. The trade was disclosed in a STOCK Act periodic transaction report filed October 12, 2026.
Since the trade, $CTVA is down 2.5% after 1 week and up 5.3% to date (from the $12.23 close on Sep 17, 2026).
Financial Disclosure Report
Clerk of the House of Representatives • Legislative Resource Center • B81 Cannon Building • Washington, DC 20515
Filer Information
- Name:
- Rep. Gilbert Ray Cisneros Jr. (D)
- Status:
- Member — House
- Party:
- Democrat
Filing Information
- Filing Type:
- Periodic Transaction Report
- Filing Year:
- 2026
- Filing Date:
- Oct 12, 2026
Schedule B: Transactions
| Asset | Transaction | Date | Amount |
|---|---|---|---|
| Corteva, Inc. ($CTVA) | Sell | Sep 17, 2026 | $1,001 - $15,000 |
Summary of the filed report, not the original document. View the original: STOCK Act disclosure (House Clerk)
CTVA
Corteva, Inc.
Key Points
- On September 17, 2026, Rep. Gilbert Ray Cisneros Jr., a Democrat from California's 31st district, sold shares of Corteva, Inc. valued between $1,001 and $15,000.
- As of October 16, 2026, Corteva's stock was trading around $13.10, which is below its 52-week high of $14.62 and significantly below the mean price target of $22.05 set by analysts.
- Corteva has a P/E ratio of 7.95 and a dividend yield of 5.59%, indicating a solid income potential for investors amidst a challenging revenue growth environment.
Get $CTVA trade alerts by text
We text you when insiders, Congress or big funds trade $CTVA. Free.
Not investment advice. EarningsIQ is not a registered investment adviser, and this automated Corteva, Inc. alert may contain errors. Disclosures
Rep. Gilbert Ray Cisneros Jr., a Democrat from California's 31st district, sold shares of Corteva, Inc. (NYSE: CTVA) on September 17, 2026. The transaction was valued between $1,001 and $15,000, as reported under the STOCK Act on October 12, 2026.
Gilbert Ray Cisneros Jr. vs. the S&P 500
Hypothetical returns from Gilbert Ray Cisneros Jr.'s disclosed trades, not real profit or advice. How we model this.
What Changed in Gilbert Ray Cisneros Jr.'s Corteva Position
Cisneros Jr. sold shares of Corteva, marking a step in his recent trading activities. This move follows a pattern of trades where he has been actively managing his portfolio, including prior sales of shares in other companies earlier this year.
Other Institutional Activity in Corteva
Several institutional investors have adjusted their positions in Corteva recently. Blackrock Inc. trimmed its holdings by 864,418 shares, leaving it with 53,845,550 shares worth about $693.5 million. Vanguard Capital Management LLC reduced its stake by 282,076 shares, resulting in a total of 43,792,285 shares valued at approximately $564 million. Meanwhile, Capital World Investors increased its position by 6,925,969 shares, bringing its total to 42,923,729 shares worth around $552.9 million. FMR, LLC also grew its holdings by 6,099,291 shares, totaling 41,072,288 shares valued at about $529 million. Lastly, State Street Corporation added 2,124,819 shares, ending with 38,261,197 shares worth approximately $492.8 million.
Corteva, Inc. Stock Up 1.7%
As of October 16, 2026, Corteva's shares were trading around $13.10, which is above its 52-week low of $9.08 but below its high of $14.62. The stock is currently above its 50-day and 200-day moving averages by 5.7% and 9.3%, respectively, which can indicate a positive trend in the stock's performance.
Recent Earnings
Corteva reported trailing twelve-month revenue of $4.97 billion and an EPS of $1.62. The company has faced a slight decline in revenue growth year-over-year at -1.2%. The next earnings report is scheduled for November 11, 2026, which could provide further insights into its financial health.
Earnings drift grade
Outlook vs expectations on the last report — not price action.
-
Forward outlook
3 analysts raised price targets.
-
EPS & revenue
EPS beat estimates by 25.4%. Revenue beat estimates by 3.6%.
-
Profit surprise
EBITDA beat by 13 percent. Operating income beat by 9 percent.
-
Pre-earnings setup
Expectations were about average.
-
Analyst signal
3 target raises.
-
Earnings quality
Gross margin up 1.5 points. Operating margin up 4.9 points. Positive free cash flow.
Earnings Call Summary
Corteva had a strong first quarter with organic sales up 7 percent, driven by seed volume growth of 6 percent and crop protection gains across all regions. Operating EBITDA jumped 21 percent year over year to over $1.4 billion, with margin expansion of 240 basis points coming from price gains, cost savings, and favorable currency effects. Management highlighted that net royalty expense fell another $30 million as the seed business moves toward royalty positive status later this year, particularly from licensing deals like Enlist soybeans in Brazil.
Guidance The company reaffirmed full-year operating EBITDA guidance of $4 billion to $4.2 billion with earnings per share of $3.45 to $3.70. Management expects continued volume growth in crop protection in Latin America in the second half, with seed pricing expected to improve in the back half despite near-term commodity cost headwinds. The company is incorporating a $40 million headwind from higher oil prices.
Good report. The company beat and showed some forward improvement, with a few meaningful caveats.
Dividend
Corteva offers a dividend rate of $0.72 per share with a yield of 5.59%. This yield is attractive for income-focused investors, especially considering the company's payout ratio of 44.4%.
Analysts Set New Price Targets
On September 16, 2026, BMO Capital maintained an 'Outperform' rating with a target price of $95.00. RBC Capital also reiterated an 'Outperform' rating with a target of $103.00. Citigroup maintained a 'Neutral' rating with a target price of $91.00 on the same day as Cisneros's sale. Argus Research later reiterated a 'Buy' rating with a target of $91.00 on September 18, 2026. The consensus among analysts is a 'Buy' recommendation with a mean target price of $22.05, significantly higher than the current trading price.
About Corteva, Inc.
Corteva, Inc. operates as a pure-play agriculture company, providing products to protect crops from pests and diseases. It focuses on enhancing crop health and productivity through innovative solutions. This recent sale by Cisneros comes as the company navigates a challenging revenue environment while offering a competitive dividend yield.
Bottom Line
Investors should keep an eye on Corteva's upcoming earnings on November 11, 2026, as this could impact stock performance. Additionally, the recent trading patterns of Gilbert Ray Cisneros Jr. may provide insights into broader market sentiments surrounding the agricultural sector.
Related Filing Alerts
Source: Gilbert Ray Cisneros Jr.'s STOCK Act disclosure on $CTVA (Sep 17, 2026). Read the original filing: STOCK Act disclosure (House Clerk). Written by software, not financial advice. How we make alerts